GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,607,000 | -13.7% | 42,700 | -6.5% | 0.05% | -21.7% |
Q2 2020 | $1,862,000 | +10.8% | 45,658 | +3.0% | 0.07% | -4.2% |
Q1 2020 | $1,680,000 | -28.4% | 44,342 | -11.2% | 0.07% | -8.9% |
Q4 2019 | $2,346,000 | +18.6% | 49,918 | +8.2% | 0.08% | +12.9% |
Q3 2019 | $1,978,000 | +2.4% | 46,121 | -4.4% | 0.07% | +4.5% |
Q2 2019 | $1,931,000 | -5.3% | 48,247 | -1.4% | 0.07% | -4.3% |
Q1 2019 | $2,038,000 | +3.6% | 48,942 | -4.9% | 0.07% | -10.3% |
Q4 2018 | $1,967,000 | -5.5% | 51,483 | -0.8% | 0.08% | +9.9% |
Q3 2018 | $2,082,000 | +8.5% | 51,876 | +8.6% | 0.07% | -1.4% |
Q2 2018 | $1,919,000 | -8.8% | 47,774 | -11.1% | 0.07% | -11.1% |
Q1 2018 | $2,104,000 | +11.7% | 53,715 | +1.3% | 0.08% | +8.0% |
Q4 2017 | $1,883,000 | -74.4% | 53,023 | -70.5% | 0.08% | -76.3% |
Q3 2017 | $7,342,000 | +179.6% | 179,678 | +194.6% | 0.32% | +170.1% |
Q2 2017 | $2,626,000 | -4.6% | 60,981 | -6.7% | 0.12% | -17.6% |
Q1 2017 | $2,752,000 | +9.2% | 65,345 | -0.1% | 0.14% | +11.8% |
Q4 2016 | $2,519,000 | +5.9% | 65,414 | +18.6% | 0.13% | +0.8% |
Q3 2016 | $2,379,000 | -13.3% | 55,160 | -12.6% | 0.13% | -17.6% |
Q2 2016 | $2,744,000 | +24.6% | 63,092 | +15.9% | 0.15% | +25.4% |
Q1 2016 | $2,203,000 | -2.4% | 54,441 | -2.7% | 0.12% | +4.3% |
Q4 2015 | $2,257,000 | +1.7% | 55,955 | -2.8% | 0.12% | -4.1% |
Q3 2015 | $2,220,000 | -7.7% | 57,577 | -0.8% | 0.12% | +13.0% |
Q2 2015 | $2,404,000 | +4.7% | 58,030 | +17.0% | 0.11% | -28.9% |
Q1 2015 | $2,296,000 | +41.4% | 49,604 | +31.2% | 0.15% | +28.8% |
Q4 2014 | $1,624,000 | +8.9% | 37,809 | +17.1% | 0.12% | 0.0% |
Q3 2014 | $1,491,000 | +45.2% | 32,283 | +67.4% | 0.12% | +57.3% |
Q2 2014 | $1,027,000 | -8.1% | 19,280 | -7.6% | 0.08% | -10.7% |
Q1 2014 | $1,117,000 | -9.0% | 20,864 | -9.0% | 0.08% | -14.3% |
Q4 2013 | $1,228,000 | -67.9% | 22,921 | -70.0% | 0.10% | -56.1% |
Q3 2013 | $3,826,000 | +292.4% | 76,305 | +291.3% | 0.22% | +185.9% |
Q2 2013 | $975,000 | – | 19,498 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |